Retinoic_JJ
acid_NN
activates_VBZ
interferon_NN
regulatory_JJ
factor-1_NN
gene_NN
expression_NN
in_IN
myeloid_JJ
cells_NNS
._.

All-trans-retinoic_JJ
acid_NN
-LRB-_-LRB-
ATRA_NN
-RRB-_-RRB-
is_VBZ
the_DT
drug_NN
of_IN
choice_NN
in_IN
the_DT
treatment_NN
of_IN
acute_JJ
promyelocytic_JJ
leukemia_NN
-LRB-_-LRB-
APL_NN
-RRB-_-RRB-
._.

ATRA_NN
induces_VBZ
both_CC
in_FW
vitro_FW
and_CC
in_FW
vivo_FW
differentiation_NN
of_IN
APL_NN
cells_NNS
into_IN
mature_JJ
granulocytes_NNS
._.

However_RB
,_,
the_DT
molecular_JJ
mechanisms_NNS
involved_VBN
in_IN
ATRA-dependent_JJ
growth_NN
inhibition_NN
and_CC
cellular_JJ
differentiation_NN
are_VBP
not_RB
presently_RB
understood_VBN
._.

The_DT
NB4_NN
cell_NN
line_NN
,_,
which_WDT
is_VBZ
derived_VBN
from_IN
the_DT
bone_NN
marrow_NN
of_IN
a_DT
patient_NN
with_IN
APL_NN
during_IN
relapse_NN
,_,
can_MD
be_VB
used_VBN
as_IN
a_DT
model_NN
system_NN
to_TO
study_VB
the_DT
growth_NN
and_CC
differentiation_NN
of_IN
APL_NN
cells_NNS
._.

Because_IN
interferon_NN
-LRB-_-LRB-
IFN_NN
-RRB-_-RRB-
regulatory_JJ
factors_NNS
-LRB-_-LRB-
IRF-1_NN
and_CC
IRF-2_NN
-RRB-_-RRB-
and_CC
other_JJ
IFN-inducible_JJ
gene_NN
products_NNS
regulate_VBP
cell_NN
growth_NN
,_,
we_PRP
analyzed_VBD
the_DT
effects_NNS
of_IN
ATRA_NN
on_IN
the_DT
expression_NN
of_IN
these_DT
genes_NNS
._.

We_PRP
show_VBP
that_IN
ATRA_NN
directly_RB
activates_VBZ
IRF-1_NN
gene_NN
expression_NN
,_,
followed_VBN
by_IN
activation_NN
of_IN
IRF-2_NN
and_CC
2_CD
'_``
-5_JJ
'_''
oligoadenylate_NN
synthetase_NN
-LRB-_-LRB-
OAS_NN
-RRB-_-RRB-
gene_NN
expression_NN
with_IN
slower_JJR
kinetics_NNS
._.

In_IN
addition_NN
to_TO
NB4_NN
cells_NNS
,_,
ATRA_NN
also_RB
activated_VBD
IRF-1_NN
gene_NN
expression_NN
in_IN
HL-60_NN
,_,
U937_NN
,_,
and_CC
THP-1_NN
cells_NNS
,_,
which_WDT
all_DT
respond_VBP
to_TO
ATRA_NN
by_IN
growth_NN
inhibition_NN
._.

A_DT
more_JJR
than_IN
additive_JJ
increase_NN
in_IN
IRF-1_NN
gene_NN
expression_NN
was_VBD
seen_VBN
with_IN
ATRA_NN
and_CC
IFN-gamma_NN
in_IN
NB4_NN
cells_NNS
._.

ATRA_NN
did_VBD
not_RB
activate_VB
nuclear_JJ
factor_NN
kappa_NN
B_NN
or_CC
signal_NN
transducer_NN
and_CC
activator_NN
of_IN
transcription_NN
-LRB-_-LRB-
STAT_NN
-RRB-_-RRB-
activation_NN
pathways_NNS
,_,
suggesting_VBG
that_IN
an_DT
alternate_JJ
mechanism_NN
is_VBZ
involved_VBN
in_IN
IRF-1_NN
gene_NN
activation_NN
._.

The_DT
ATRA-induced_JJ
expression_NN
of_IN
IRF-1_NN
,_,
an_DT
activator_NN
of_IN
transcription_NN
and_CC
repressor_NN
of_IN
transformation_NN
,_,
may_MD
be_VB
one_CD
of_IN
the_DT
molecular_JJ
mechanisms_NNS
of_IN
ATRA-induced_JJ
growth_NN
inhibition_NN
,_,
and_CC
the_DT
basis_NN
for_IN
the_DT
synergistic_JJ
actions_NNS
of_IN
ATRA_NN
and_CC
IFNs_NNS
in_IN
myeloid_JJ
leukemia_NN
cells_NNS
._.

